Literature DB >> 15331549

Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes.

Raffaele Marfella1, Katherine Esposito, Francesco Nappo, Mario Siniscalchi, Ferdinando Carlo Sasso, Michele Portoghese, Maria Pia Di Marino, Alfonso Baldi, Salvatore Cuzzocrea, Clara Di Filippo, Guglielmo Barboso, Feliciano Baldi, Francesco Rossi, Michele D'Amico, Dario Giugliano.   

Abstract

Inadequate angiogenic response to ischemia in diabetic myocardium could result in poor collateral formation. Because hypoxia-inducible factor (HIF)-1alpha is a transcriptional activator of vascular endothelial growth factor (VEGF) and is critical for initiating angiogenic responses to hypoxia, we investigated the expression of HIF-1alpha and VEGF in specimens of human heart tissue to elucidate the molecular responses to myocardial ischemia in diabetic patients during unstable angina. Moreover, accumulation of a marker of protein nitration nitrotyrosine, as well as the superoxide anion (O(2)(-)) levels and inducible nitric oxide synthase (iNOS), were evaluated. Ventricular biopsy specimens from 15 type 2 diabetic and 14 nondiabetic patients presenting with unstable angina (ischemic group) and from 20 patients (11 type 2 diabetic and 9 nondiabetic patients) who underwent coronary bypass surgery without angina within the preceding 10 days (control group) were collected during coronary bypass surgery. Nondiabetic patients had higher HIF-1alpha and VEGF expressions compared with diabetic patients (P < 0.001). As compared with nondiabetic specimens, diabetic specimens showed higher levels of both iNOS mRNA and protein levels (P < 0.001) associated with the highest tissue levels of nitrotyrosine and O(2)(-) (P < 0.001). Diabetes is associated with increased myocardial tissue levels of iNOS, O(2)(-), and nitrotyrosine and reduced expression of myocardial angiogenesis factors during ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331549     DOI: 10.2337/diabetes.53.9.2383

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  33 in total

Review 1.  Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia.

Authors:  Sergiu-Bogdan Catrina
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

2.  Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose.

Authors:  Debashis Nandy; Debabrata Mukhopadhyay; Ananda Basu
Journal:  J Investig Med       Date:  2010-08       Impact factor: 2.895

3.  Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy.

Authors:  Adriana Georgescu
Journal:  World J Diabetes       Date:  2011-06-15

4.  Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.

Authors:  Heng Zeng; Xiaochen He; Xuwei Hou; Lanfang Li; Jian-Xiong Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-20       Impact factor: 4.733

5.  Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome.

Authors:  Raffaele Marfella; Clara Di Filippo; Michele Portoghese; Michelangela Barbieri; Franca Ferraraccio; Mario Siniscalchi; Federico Cacciapuoti; Francesco Rossi; Michele D'Amico; Giuseppe Paolisso
Journal:  J Lipid Res       Date:  2009-05-24       Impact factor: 5.922

6.  Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice.

Authors:  Jian-Xiong Chen; Amanda Stinnett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

7.  Impaired transcriptional response of the murine heart to cigarette smoke in the setting of high fat diet and obesity.

Authors:  Susan C Tilton; Norman J Karin; Bobbie-Jo M Webb-Robertson; Katrina M Waters; Vladimir Mikheev; K Monica Lee; Richard A Corley; Joel G Pounds; Diana J Bigelow
Journal:  Chem Res Toxicol       Date:  2013-06-20       Impact factor: 3.739

8.  Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease.

Authors:  Po-Chao Hsu; Suh-Hang Juo; Ho-Ming Su; Szu-Chia Chen; Wei-chung Tsai; Wen-Ter Lai; Sheng-Hsiung Sheu; Tsung-Hsien Lin
Journal:  BMC Nephrol       Date:  2012-08-30       Impact factor: 2.388

9.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11

10.  Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation.

Authors:  Latt S Mansor; Keshavi Mehta; Dunja Aksentijevic; Carolyn A Carr; Trine Lund; Mark A Cole; Lydia Le Page; Maria da Luz Sousa Fialho; Michael J Shattock; Ellen Aasum; Kieran Clarke; Damian J Tyler; Lisa C Heather
Journal:  J Physiol       Date:  2015-12-20       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.